Science and Technology of Nuclear Installations / 2013 / Article / Tab 1

Research Article

Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals

Table 1

Radiopharmaceuticals used in the study.

NameRadiopharmaceutical

Neurolite (Brystol-Myer Squibb) 99mTc-ECD (99mTc-Bicisato)
Cardiolite (Brystol-Myer Squibb) 99mTc-SESTAMIBI
Stamicis (IBA) 99mTc-SESTAMIBI
Technemibi (Mallinckrodt) 99mTc-SESTAMIBI
TechneScan (Mallinckrodt) 99mTc-MAG3
Pentacis (IBA) 99mTc-DTPA
Medronato II (GE Healthcare)
Osteocis (IBA)
99mTc-MDP
99mTc-HMDP
Nanocoll (GE Healthcare) 99mTc-nanocolloids
Renocis (IBA) 99mTc-DMSA

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.